Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association

BW McCrindle, AH Rowley, JW Newburger, JC Burns… - circulation, 2017 - Am Heart Assoc
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary
artery aneurysms in≈ 25% of untreated cases. It has been reported worldwide and is the …

2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused …

FG Kushner, M Hand, SC Smith Jr, SB King III… - Circulation, 2009 - Am Heart Assoc
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation
Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI …

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Clopidogrel in Unstable Angina to Prevent … - … England Journal of …, 2001 - Mass Medical Soc
Background Despite current treatments, patients who have acute coronary syndromes
without ST-segment elevation have high rates of major vascular events. We evaluated the …

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis …

JW Newburger, M Takahashi, MA Gerber, MH Gewitz… - Circulation, 2004 - Am Heart Assoc
Background—Kawasaki disease is an acute self-limited vasculitis of childhood that is
characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral …

Acute coronary syndromes: diagnosis and management, part I

A Kumar, CP Cannon - Mayo Clinic Proceedings, 2009 - Elsevier
The term acute coronary syndrome (ACS) refers to any group of clinical symptoms
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

SR Mehta, S Yusuf, RJG Peters, ME Bertrand… - The Lancet, 2001 - thelancet.com
Background Despite the use of aspirin, there is still a risk of ischaemic events after
percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to …

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy

SR Mehta, KR Bainey, WJ Cantor… - Canadian Journal of …, 2018 - Elsevier
Antiplatelet therapy (APT) has become an important tool in the treatment and prevention of
atherosclerotic events, particularly those associated with coronary artery disease. A large …

[HTML][HTML] Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment

G Paré, SR Mehta, S Yusuf, SS Anand… - … England Journal of …, 2010 - Mass Medical Soc
Background It has been suggested that clopidogrel may be less effective in reducing the rate
of cardiovascular events among persons who are carriers of loss-of-function CYP2C19 …

Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association

TM Giglia, MP Massicotte, JS Tweddell, RJ Barst… - Circulation, 2013 - Am Heart Assoc
Thrombosis has long been recognized as a potentially lifethreatening complication in
children with congenital heart disease (CHD), children with acquired heart disease, and in …

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable …

RJG Peters, SR Mehta, KAA Fox, F Zhao, BS Lewis… - Circulation, 2003 - Am Heart Assoc
Background—We studied the benefits and risks of adding clopidogrel to different doses of
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …